Headline News

 

Janssen’s Investigational Preventive Ebola Vaccine Regimen Receives Positive CHMP

Posted on June 01, 2020

CHMP Recommends Lynparza for Approval in EU for BRCA-mutated Metastatic Pancreatic Cancer

Posted on June 01, 2020

Brilinta Approved in the US to Reduce the Risk for Patients With Coronary Artery Disease

Posted on June 01, 2020

Merck and Ridgeback Bio Collaborate for Development of Novel Antiviral Candidate EIDD-2801

Posted on May 28, 2020

Multiple Scientific Efforts to Combat COVID-19 to Announced by Merck

Posted on May 28, 2020

NewAge® Industries Purchases Additional Facility to Increase Capacity & Ensure Continuity of Product Manufacturing

Posted on May 27, 2020

Dupixent® Eosinophilic Esophagitis Trial Meets Both Co-primary Endpoints

Posted on May 26, 2020

Positive Topline Results Announced by Gilead and Galapagos for Phase 2b/3 Trial of Filgotinib in Moderately to Severely Active Ulcerative Colitis

Posted on May 26, 2020

New Collaboration With AstraZeneca and ArcherDX to Use Personalised Cancer Assays to Detect Minimal Residual Disease in Lung Cancer Trials

Posted on May 26, 2020

Glenmark to Commence Another New Phase 3 Clinical Trial in Hospitalized Patients of Moderate COVID-19 on a Combination of Two Anti-viral Drugs Favipiravir and Umifenovir 

Posted on May 26, 2020

European Medicines Agency Validates Bristol Myers Squibb’s Idecabtagene Vicleucel Application

Posted on May 26, 2020

GSK Partners With Samsung Biologics to Secure Innovative Biopharmaceutical Portfolio

Posted on May 22, 2020

Lynparza Approved for HRR Gene-mutated Metastatic Castration-resistant Prostate Cancer in the US 

Posted on May 21, 2020

AstraZeneca Receives First Commitments for Oxford’s Potential New Vaccine and Advances it’s Response to Global COVID-19 Challenge 

Posted on May 21, 2020

Biogen’s Commitment to Advancing Innovation in MS New Data Showcased at AAN

Posted on May 20, 2020